ATE160943T1 - Bicycloazamakrocyclophosphon-säure, komplexe, konjugate, kontrastmittel und herstellung - Google Patents

Bicycloazamakrocyclophosphon-säure, komplexe, konjugate, kontrastmittel und herstellung

Info

Publication number
ATE160943T1
ATE160943T1 AT93901000T AT93901000T ATE160943T1 AT E160943 T1 ATE160943 T1 AT E160943T1 AT 93901000 T AT93901000 T AT 93901000T AT 93901000 T AT93901000 T AT 93901000T AT E160943 T1 ATE160943 T1 AT E160943T1
Authority
AT
Austria
Prior art keywords
complexes
conjugates
preparation
contrast agents
bicycloazamacrocyclophosphone
Prior art date
Application number
AT93901000T
Other languages
English (en)
Inventor
Garry E Kiefer
Jaime Simon
Joseph R Garlich
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Application granted granted Critical
Publication of ATE160943T1 publication Critical patent/ATE160943T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0497Organic compounds conjugates with a carrier being an organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT93901000T 1991-12-10 1992-12-10 Bicycloazamakrocyclophosphon-säure, komplexe, konjugate, kontrastmittel und herstellung ATE160943T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80555191A 1991-12-10 1991-12-10

Publications (1)

Publication Number Publication Date
ATE160943T1 true ATE160943T1 (de) 1997-12-15

Family

ID=25191891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93901000T ATE160943T1 (de) 1991-12-10 1992-12-10 Bicycloazamakrocyclophosphon-säure, komplexe, konjugate, kontrastmittel und herstellung

Country Status (18)

Country Link
EP (2) EP0570575B1 (de)
JP (1) JPH07502043A (de)
CN (1) CN1038328C (de)
AT (1) ATE160943T1 (de)
AU (1) AU3246893A (de)
CA (1) CA2103556C (de)
DE (1) DE69223504T2 (de)
DK (1) DK0570575T3 (de)
ES (1) ES2110593T3 (de)
GR (1) GR3026121T3 (de)
HK (1) HK1006654A1 (de)
HU (1) HUT66220A (de)
IL (1) IL104060A (de)
MX (1) MX9207166A (de)
RU (1) RU2114115C1 (de)
SG (1) SG46598A1 (de)
WO (1) WO1993011802A1 (de)
ZA (1) ZA929576B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5385893A (en) * 1993-05-06 1995-01-31 The Dow Chemical Company Tricyclopolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
EP0696290A1 (de) * 1993-05-06 1996-02-14 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonsäure, ihre komplexe und konjugate zur verwendung als contrastmittel, und verfahren zu ihrer herstellung
US6207826B1 (en) 1995-03-27 2001-03-27 Isis Pharmaceuticals, Inc. Macrocyclic compounds having nitrogen-containing linkages
EP0817787A4 (de) * 1995-03-27 2000-09-13 Isis Pharmaceuticals Inc Makrozyklische stickstoffverbindungen
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
CA2251924C (en) * 1996-04-19 2006-05-30 The Dow Chemical Company Fluorescent chelates as visual tissue specific imaging agents
US5888476A (en) * 1996-11-13 1999-03-30 Mallinckrodt Medical, Inc. Magnetic resonance blood pool agents
US6440389B1 (en) 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US8211401B2 (en) * 2008-12-05 2012-07-03 Molecular Insight Pharmaceuticals, Inc. Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting PSMA
NO331773B1 (no) * 2009-12-18 2012-03-26 Ge Healthcare As Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
GB201610738D0 (en) 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
ES2813077T3 (es) * 2016-12-21 2021-03-22 Ge Healthcare As Compuestos quelatos de manganeso basados en macrociclo de tetraazabiciclo adecuados como agentes de imagen de IRM

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825040A1 (de) * 1988-07-20 1990-01-25 Schering Ag, 13353 Berlin 5- oder 6-ring- enthaltende makrocyclische polyaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
DE4001655A1 (de) * 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
FR2644785B1 (fr) * 1989-03-24 1991-07-05 Guerbet Sa Nouveaux ligands macrocycliques azotes, procede de preparation, complexes metalliques formes par ces ligands et composition de diagnostic les contenant
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
EP0511275A1 (de) * 1990-01-19 1992-11-04 Nycomed Imaging As Komplexbildner
GB9001245D0 (en) * 1990-01-19 1990-03-21 Salutar Inc Compounds

Also Published As

Publication number Publication date
AU3246893A (en) 1993-07-19
HU9302312D0 (en) 1993-12-28
HUT66220A (en) 1994-10-28
SG46598A1 (en) 1998-02-20
DK0570575T3 (da) 1998-08-24
IL104060A0 (en) 1993-05-13
HK1006654A1 (en) 1999-03-12
WO1993011802A1 (en) 1993-06-24
IL104060A (en) 1998-12-06
CA2103556C (en) 2002-04-16
MX9207166A (es) 1993-07-01
CN1074447A (zh) 1993-07-21
ZA929576B (en) 1994-06-10
RU2114115C1 (ru) 1998-06-27
DE69223504T2 (de) 1998-04-02
JPH07502043A (ja) 1995-03-02
EP0735040A2 (de) 1996-10-02
EP0570575A1 (de) 1993-11-24
ES2110593T3 (es) 1998-02-16
EP0570575B1 (de) 1997-12-10
DE69223504D1 (de) 1998-01-22
EP0735040A3 (de) 1997-02-26
GR3026121T3 (en) 1998-05-29
CN1038328C (zh) 1998-05-13
CA2103556A1 (en) 1993-06-11

Similar Documents

Publication Publication Date Title
FI955319A0 (fi) 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina
ATE316377T1 (de) Tricyclopolyazamacrocyclophosphonsäuren, ihre komplexe und derivate, für eine verwendung als kontrastmittel
DE69223504D1 (de) Bicycloazamakrocyclophosphon-Säure, Komplexe, Konjugate, Kontrastmittel und Herstellung
ATE192047T1 (de) Bicylclische, polyazamakrocyclocarbonsäure- komplexe, konjugate, herstellung und verwendung als kontraststoffe
RU93053767A (ru) Бициклополиазамакроциклофосфоновые кислоты, их комплексы и конъюгаты для применения в качестве контрастных агентов и способы их получения
NO954442L (no) Bicyklopolyazamakrocyklofosfonsyrer, deres komplekser og konjugater, for anvendelse som kontrastmidler, og fremgangsmåter for deres fremstilling
MY141501A (en) Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents and processes for their preparation
RU93053897A (ru) Комплексы бициклополиазамакроциклокарбоновых кислот, их конъюгаты, фармацевтическая композиция, способ диагностики, набор и способ получения
MY109649A (en) Bicyclopol yazamacrocyclocarboxylic acid complexes, and conjugates, processes for their prepration, and use as contrast agents

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee